- call +1-201-465-4211
- email sales@mrinsights.biz
Intravenous therapy (IV) is a therapy that delivers liquid substances directly into a vein. The intravenous route of administration can be used for injections (with a syringe at higher pressures) or infusions (typically using only the pressure supplied by gravity). Intravenous infusions are commonly referred to as drips. The intravenous route is the fastest way to deliver medications and fluid replacement throughout the body, because the circulation carries them. Intravenous therapy may be used for fluid replacement (such as correcting dehydration), to correct electrolyte imbalances, to deliver medications, and for blood transfusions.
Scope of the Report:
This report studies the Intravenous Solutions market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Intravenous Solutions market by product type and applications/end industries.
The major factor driving the growth of the intravenous solutions market is the availability of intravenous products in portable packaging which makes it easier for consumers to use them in a home setting as well. Additionally, through innovation, vendors are able to offer premixed products for increased convenience and reduced waste and disposal costs which is further likely to impact the market growth. Further, with the rising prevalence of chronic diseases and gastrointestinal disorders, the adoption of intravenous solutions is rising among the consumers. Moreover, the governments in the developing countries are increasing the investment in the healthcare sector, thereby driving the demand for intravenous solutions.
North America currently holds the majority of the global intravenous solutions market, followed by Europe and Asia Pacific. Other major regions include the Middle East and Africa, and Latin America.
The global Intravenous Solutions market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Intravenous Solutions.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Ajinomoto
B. Braun Melsungen
Baxter International
Grifols
Otsuka Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Total Parenteral Nutrition (TPN)
Peripheral Parenteral Nutrition (PPN)
Market Segment by Applications, can be divided into
Basic IV Solutions
Nutrient Infusion Solution
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Intravenous Solutions Market Overview
1.1 Product Overview and Scope of Intravenous Solutions
1.2 Classification of Intravenous Solutions by Types
1.2.1 Global Intravenous Solutions Revenue Comparison by Types (2017-2023)
1.2.2 Global Intravenous Solutions Revenue Market Share by Types in 2017
1.2.3 Total Parenteral Nutrition (TPN)
1.2.4 Peripheral Parenteral Nutrition (PPN)
1.3 Global Intravenous Solutions Market by Application
1.3.1 Global Intravenous Solutions Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Basic IV Solutions
1.3.3 Nutrient Infusion Solution
1.3.4 Others
1.4 Global Intravenous Solutions Market by Regions
1.4.1 Global Intravenous Solutions Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Intravenous Solutions Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Intravenous Solutions Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Intravenous Solutions Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Intravenous Solutions Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Intravenous Solutions Status and Prospect (2013-2023)
1.5 Global Market Size of Intravenous Solutions (2013-2023)
2 Manufacturers Profiles
2.1 Ajinomoto
2.1.1 Business Overview
2.1.2 Intravenous Solutions Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Ajinomoto Intravenous Solutions Revenue, Gross Margin and Market Share (2016-2017)
2.2 B. Braun Melsungen
2.2.1 Business Overview
2.2.2 Intravenous Solutions Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 B. Braun Melsungen Intravenous Solutions Revenue, Gross Margin and Market Share (2016-2017)
2.3 Baxter International
2.3.1 Business Overview
2.3.2 Intravenous Solutions Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Baxter International Intravenous Solutions Revenue, Gross Margin and Market Share (2016-2017)
2.4 Grifols
2.4.1 Business Overview
2.4.2 Intravenous Solutions Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Grifols Intravenous Solutions Revenue, Gross Margin and Market Share (2016-2017)
2.5 Otsuka Pharmaceutical
2.5.1 Business Overview
2.5.2 Intravenous Solutions Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Otsuka Pharmaceutical Intravenous Solutions Revenue, Gross Margin and Market Share (2016-2017)
3 Global Intravenous Solutions Market Competition, by Players
3.1 Global Intravenous Solutions Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Intravenous Solutions Players Market Share
3.2.2 Top 10 Intravenous Solutions Players Market Share
3.3 Market Competition Trend
4 Global Intravenous Solutions Market Size by Regions
4.1 Global Intravenous Solutions Revenue and Market Share by Regions
4.2 North America Intravenous Solutions Revenue and Growth Rate (2013-2018)
4.3 Europe Intravenous Solutions Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Intravenous Solutions Revenue and Growth Rate (2013-2018)
4.5 South America Intravenous Solutions Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Intravenous Solutions Revenue and Growth Rate (2013-2018)
5 North America Intravenous Solutions Revenue by Countries
5.1 North America Intravenous Solutions Revenue by Countries (2013-2018)
5.2 USA Intravenous Solutions Revenue and Growth Rate (2013-2018)
5.3 Canada Intravenous Solutions Revenue and Growth Rate (2013-2018)
5.4 Mexico Intravenous Solutions Revenue and Growth Rate (2013-2018)
6 Europe Intravenous Solutions Revenue by Countries
6.1 Europe Intravenous Solutions Revenue by Countries (2013-2018)
6.2 Germany Intravenous Solutions Revenue and Growth Rate (2013-2018)
6.3 UK Intravenous Solutions Revenue and Growth Rate (2013-2018)
6.4 France Intravenous Solutions Revenue and Growth Rate (2013-2018)
6.5 Russia Intravenous Solutions Revenue and Growth Rate (2013-2018)
6.6 Italy Intravenous Solutions Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Intravenous Solutions Revenue by Countries
7.1 Asia-Pacific Intravenous Solutions Revenue by Countries (2013-2018)
7.2 China Intravenous Solutions Revenue and Growth Rate (2013-2018)
7.3 Japan Intravenous Solutions Revenue and Growth Rate (2013-2018)
7.4 Korea Intravenous Solutions Revenue and Growth Rate (2013-2018)
7.5 India Intravenous Solutions Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Intravenous Solutions Revenue and Growth Rate (2013-2018)
8 South America Intravenous Solutions Revenue by Countries
8.1 South America Intravenous Solutions Revenue by Countries (2013-2018)
8.2 Brazil Intravenous Solutions Revenue and Growth Rate (2013-2018)
8.3 Argentina Intravenous Solutions Revenue and Growth Rate (2013-2018)
8.4 Colombia Intravenous Solutions Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Intravenous Solutions by Countries
9.1 Middle East and Africa Intravenous Solutions Revenue by Countries (2013-2018)
9.2 Saudi Arabia Intravenous Solutions Revenue and Growth Rate (2013-2018)
9.3 UAE Intravenous Solutions Revenue and Growth Rate (2013-2018)
9.4 Egypt Intravenous Solutions Revenue and Growth Rate (2013-2018)
9.5 Nigeria Intravenous Solutions Revenue and Growth Rate (2013-2018)
9.6 South Africa Intravenous Solutions Revenue and Growth Rate (2013-2018)
10 Global Intravenous Solutions Market Segment by Type
10.1 Global Intravenous Solutions Revenue and Market Share by Type (2013-2018)
10.2 Global Intravenous Solutions Market Forecast by Type (2018-2023)
10.3 Total Parenteral Nutrition (TPN) Revenue Growth Rate (2013-2023)
10.4 Peripheral Parenteral Nutrition (PPN) Revenue Growth Rate (2013-2023)
11 Global Intravenous Solutions Market Segment by Application
11.1 Global Intravenous Solutions Revenue Market Share by Application (2013-2018)
11.2 Intravenous Solutions Market Forecast by Application (2018-2023)
11.3 Basic IV Solutions Revenue Growth (2013-2018)
11.4 Nutrient Infusion Solution Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Intravenous Solutions Market Size Forecast (2018-2023)
12.1 Global Intravenous Solutions Market Size Forecast (2018-2023)
12.2 Global Intravenous Solutions Market Forecast by Regions (2018-2023)
12.3 North America Intravenous Solutions Revenue Market Forecast (2018-2023)
12.4 Europe Intravenous Solutions Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Intravenous Solutions Revenue Market Forecast (2018-2023)
12.6 South America Intravenous Solutions Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Intravenous Solutions Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Intravenous Solutions Picture
Table Product Specifications of Intravenous Solutions
Table Global Intravenous Solutions and Revenue (Million USD) Market Split by Prod
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
